IL17F and Alzheimer disease: While the role of type 2 inflammation in AD is well‐established, new techniques, including single‐cell analysis, have revealed that pathways linked to type 1 (IFN‐γ) and type 3 (IL‐17A, IL‐17F) responses are also activated in AD skin lesions [5, 6].